These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34673001)

  • 1. Targeting cryptic-orthosteric site of PD-L1 for inhibitor identification using structure-guided approach.
    Mittal L; Tonk RK; Awasthi A; Asthana S
    Arch Biochem Biophys; 2021 Nov; 713():109059. PubMed ID: 34673001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing the druggability at orthosteric and allosteric sites of PD-1 for small molecule discovery by an integrated in silico pipeline.
    Mittal L; Tonk RK; Awasthi A; Asthana S
    Comput Biol Chem; 2023 Dec; 107():107965. PubMed ID: 37826990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragment-based screening of programmed death ligand 1 (PD-L1).
    Perry E; Mills JJ; Zhao B; Wang F; Sun Q; Christov PP; Tarr JC; Rietz TA; Olejniczak ET; Lee T; Fesik S
    Bioorg Med Chem Lett; 2019 Mar; 29(6):786-790. PubMed ID: 30728114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of protein-protein interactions and hot spot region between PD-1 and PD-L1 by fragment molecular orbital method.
    Lim H; Chun J; Jin X; Kim J; Yoon J; No KT
    Sci Rep; 2019 Nov; 9(1):16727. PubMed ID: 31723178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into non-peptide small-molecule inhibitors of the PD-1/PD-L1 interaction: Development and perspective.
    Wu X; Meng Y; Liu L; Gong G; Zhang H; Hou Y; Liu C; Wu D; Qin M
    Bioorg Med Chem; 2021 Mar; 33():116038. PubMed ID: 33517226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multitier virtual screening of antagonists targeting PD-1/PD-L1 interface for the management of triple-negative breast cancer.
    Krishnamoorthy HR; Karuppasamy R
    Med Oncol; 2023 Sep; 40(11):312. PubMed ID: 37777635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the origins of programmed death ligand-1 inhibition by implementing machine learning-assisted sequential virtual screening techniques.
    Kuttappan S; Bhowmik R; Gopi Mohan C
    Mol Divers; 2024 Aug; 28(4):2449-2466. PubMed ID: 37470920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of Biphenyl-Conjugated Bromotyrosine for Inhibition of PD-1/PD-L1 Immune Checkpoint Interactions.
    Kim EH; Kawamoto M; Dharmatti R; Kobatake E; Ito Y; Miyatake H
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Mechanism of Small-Molecule Inhibitors in Blocking the PD-1/PD-L1 Pathway through PD-L1 Dimerization.
    Guo Y; Jin Y; Wang B; Liu B
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein-Protein Interaction.
    Klimek J; Kruc O; Ceklarz J; Kamińska B; Musielak B; van der Straat R; Dӧmling A; Holak TA; Muszak D; Kalinowska-Tłuścik J; Skalniak Ł; Surmiak E
    Molecules; 2024 Jun; 29(11):. PubMed ID: 38893521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico exploration of PD-L1 binding compounds: Structure-based virtual screening, molecular docking, and MD simulation.
    Alanzi A; Moussa AY; Mothana RA; Abbas M; Ali I
    PLoS One; 2024; 19(8):e0306804. PubMed ID: 39121024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1).
    Zak KM; Grudnik P; Guzik K; Zieba BJ; Musielak B; Dömling A; Dubin G; Holak TA
    Oncotarget; 2016 May; 7(21):30323-35. PubMed ID: 27083005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanism of Food-Derived Polyphenols on PD-L1 Dimerization: A Molecular Dynamics Simulation Study.
    Guo Y; Liang J; Liu B; Jin Y
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the FDA-Approved Drug Pyrvinium as a Small-Molecule Inhibitor of the PD-1/PD-L1 Interaction.
    Fattakhova E; Hofer J; DiFlumeri J; Cobb M; Dando T; Romisher Z; Wellington J; Oravic M; Radnoff M; Patil SP
    ChemMedChem; 2021 Sep; 16(18):2769-2774. PubMed ID: 34117723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive in vitro characterization of PD-L1 small molecule inhibitors.
    Ganesan A; Ahmed M; Okoye I; Arutyunova E; Babu D; Turnbull WL; Kundu JK; Shields J; Agopsowicz KC; Xu L; Tabana Y; Srivastava N; Zhang G; Moon TC; Belovodskiy A; Hena M; Kandadai AS; Hosseini SN; Hitt M; Walker J; Smylie M; West FG; Siraki AG; Lemieux MJ; Elahi S; Nieman JA; Tyrrell DL; Houghton M; Barakat K
    Sci Rep; 2019 Aug; 9(1):12392. PubMed ID: 31455818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Novel Small-Molecule Inhibitors of PD-1/PD-L1 Interaction via Structural Simplification Strategy.
    Zhang H; Xia Y; Yu C; Du H; Liu J; Li H; Huang S; Zhu Q; Xu Y; Zou Y
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34199417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel PD-1/PD-L1 small molecule inhibitors: virtual screening, synthesis and
    Wu T; Cheng H; Sima L; Wang Z; Ouyang W; Wang J; Hou Y; Zhao D; Liao W; Hu C
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2353711. PubMed ID: 38887057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of phenyl-linked symmetric small molecules as inhibitors of the programmed cell death-1/programmed cell death-ligand 1 interaction.
    Wu Y; Zhang Y; Guo Y; Pan Z; Zhong S; Jin X; Zhuang W; Chen S; Gao J; Huang W; Dong X; Che J
    Eur J Med Chem; 2021 Nov; 223():113637. PubMed ID: 34147746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1.
    Guzik K; Zak KM; Grudnik P; Magiera K; Musielak B; Törner R; Skalniak L; Dömling A; Dubin G; Holak TA
    J Med Chem; 2017 Jul; 60(13):5857-5867. PubMed ID: 28613862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.